Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
GC Biopharma Corp (006280 KS)
Watchlist
101
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
LG Chem Ltd
•
14 Jan 2022 01:51
KRX K-New Deal Index Rebalancing: Detailed Methodology & Changes Preview
This post details the full methodology of the KRX K-New Deal Index Rebalancing and previews likely changes in the upcoming rebalancing.
Sanghyun Park
Follow
546 Views
Share
bullish
•
LG Energy Solution
•
12 Jan 2022 11:59
KRX BBIG Index Rebalance Preview (March): LG Energy Should Be Added; Plus Other Changes
LG Energy should be added to the Secondary Battery and BBIG indices. There are changes to the Bio, Internet and Game indices too. Douzone Bizon...
Brian Freitas
Follow
594 Views
Share
bullish
•
Yuhan Corp
•
21 Dec 2021 15:49
Yuhan Corp (000100 KS): R&D Endeavors Finally Began to Pay Back; Lazertinib to Drive Future Growth
R&D investment is generating highest-margin earning outlicensing revenue stream. In-house developed drug, lazertinib is the biggest growth engine...
Tina Banerjee
Follow
331 Views
Share
bullish
•
SK Bioscience
•
20 Jul 2021 03:53
KRX BBIG Rebalancing Complete Preview: SK Bioscience, SK IE Tech, Krafton, Kakao Games, & Kakao Pay
This post is a complete preview of the KRX BBIG rebalancing, featuring SK Bioscience, SK IE Technology, Kakao Games, Krafton, Kakao Pay, SD...
Sanghyun Park
Follow
493 Views
Share
bullish
•
Green Cross LabCell
•
20 Jul 2021 00:47
Green Cross Merger Swap Summary & Arb Spread Status
This merger swap is very similar to the recent case of the GS merger swap. So, we are likely to face a rather juicy swap spread opening probably 2...
Sanghyun Park
Follow
361 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x